![]() |
|
|
Vol. 58, Issue 2, 421-430, August 2000
2-Adrenergic Receptor in BEAS-2B Cells Reveals High- and
Low-Affinity Components
Department of Integrative Biology and Pharmacology, The University
of Texas Medical School, Houston, Texas
We examined the interrelationships of internalization and
down-regulation of the
2-adrenergic receptor in
response to treatment of the BEAS-2B human epithelial cell line with
both a series of agonists at high occupancy and with various
concentrations of fenoterol that gave occupancies from 0.93 to 0.001. We found that the extent of internalization measured after a 30-min
treatment increased as a function of coupling efficiency, with
ephedrine, dobutamine, albuterol, fenoterol, and epinephrine giving 0, 7, 17, 48, and 55% internalization, respectively. With the exception of dobutamine, the rates of down-regulation
(kdeg) also showed a dependence on agonist
coupling efficiency, giving (in terms of fraction of receptors lost/h)
0.082 with ephedrine, 0.250 with dobutamine, 0.148 with albuterol,
0.194 with fenoterol, and 0.212 with epinephrine. Comparison of
down-regulation to internalization showed that weak agonists caused
down-regulation in the absence of significant internalization. The
extent of internalization caused by fenoterol over a 1000-fold range of
occupancy was proportional to agonist occupancy. However, although no
internalization was observed with the low concentrations (0.2 and 2 nM
fenoterol), these concentrations did cause significant down-regulation.
Thus, as with partial agonists, it was clear that down-regulation
occurred in the absence of measurable internalization. The kinetics of agonist-induced down-regulation are consistent with a scheme in which
down-regulation proceeds by two pathways; a high-affinity, low-capacity
component (EC50 = 0.5 nM) clearly dissociated from internalization and a low-affinity, high-capacity component
(EC50 = 160 nM) closely correlated with internalization.
This article has been cited by other articles:
![]() |
R. H. Moore, E. E. Millman, V. Godines, N. A. Hanania, T. M. Tran, H. Peng, B. F. Dickey, B. J. Knoll, and R. B. Clark Salmeterol Stimulation Dissociates beta2-Adrenergic Receptor Phosphorylation and Internalization Am. J. Respir. Cell Mol. Biol., February 1, 2007; 36(2): 254 - 261. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Tran, J. Friedman, E. Qunaibi, F. Baameur, R. H. Moore, and R. B. Clark Characterization of Agonist Stimulation of cAMP-Dependent Protein Kinase and G Protein-Coupled Receptor Kinase Phosphorylation of the {beta}2-Adrenergic Receptor Using Phosphoserine-Specific Antibodies Mol. Pharmacol., January 1, 2004; 65(1): 196 - 206. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Liang, S. Austin, Q. Hoang, and P. H. Fishman Resistance of the Human {beta}1-Adrenergic Receptor to Agonist-mediated Down-regulation: ROLE OF THE C TERMINUS IN DETERMINING {beta}-SUBTYPE DEGRADATION J. Biol. Chem., October 10, 2003; 278(41): 39773 - 39781. [Abstract] [Full Text] [PDF] |
||||